Huawei Plans to Expand AI Drug Development and Clinical Collaboration
NVDA NVIDIA Corp
$209.96 -1.45%
View chart & analysis → - 1Huawei plans to expand AI collaboration with local pharmaceutical companies into drug development and clinical practice
- 2Healthcare President William Zhang seeks further opportunities with domestic pharmaceutical firms while continuing hospital clinical partnerships
- 3Aims to build a foothold in the AI drug discovery market by providing candidate compound screening, Ascend and Kunpeng chips
This 3-line summary is compiled from the report below.
Reuters View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다